VANCOUVER, British Columbia, Oct. 2 /PRNewswire-FirstCall/ -- The following was issued today by Robert Kramer, Director, Current Technology Corporation :
Strategic Laser & MedSpa, LLC (“Strategic Laser”) has requested, and Current Technology Corporation (the “Company”) has granted, a further extension of the interim sales agreement (the “Agreement”) to October 6, 2006. The Agreement provides for the placement on a revenue sharing basis of the Company’s proprietary TrichoGenesis platform products in the United States.
“We just need a few more days to complete documentation,” states Strategic Laser CEO Jason Olcese. “The financial resources required to proceed are in hand, and we will take delivery of the first CosmeticTrichoGenesis (“CTG”) units shortly. Later in the week we will reveal the details of a marketing strategy that we believe will make CTG a household name in the United States.”
“We will deliver the first CTG units to high profile Southern California salons designated by Strategic Laser,” states Company CEO Robert Kramer. “We are very excited about the marketing strategy and believe success is inevitable.”
The news release contains forward-looking statements concerning the Company’s business operations, and financial performance and condition. When used in the news release the words “believe”, “anticipate”, “intend”, “estimate”, “expect”, “project”, and similar expressions are intended to identify forward-looking statements, although not all forward-looking statements contains such words. These forward-looking statements are based on current expectations and are naturally subject to uncertainty and changes in circumstances that may cause actual results to differ materially from those expressed or implied by such forward-looking statements. Factors that may cause such differences include but are not limited to technological change, regulatory change, the general health of the economy and competitive factors. Many of these factors are beyond the Company’s control; therefore, future events may vary substantially from what the Company’s currently foresees. You should not place undue reliance on such forward-looking statements.
ABOUT CURRENT TECHNOLOGY CORPORATION
Current Technology Corporation remains committed to developing its non-invasive pulsed electro-stimulation technology. This technology has enabled the Company to develop two separate and distinct products emanating from the TrichoGenesis platform, thus far, that offer help for those concerned with their hair: ElectroTrichoGenesis (ETG) and CosmeticTrichoGenesis (CTG). Current Technology holds patents throughout the world and has spent over US $15 million in research and development of its TrichoGenesis platform and systems. The patents encompass the technology, methodology and design of the Company’s products.
Current Technology Corporation
CONTACT: Robert Kramer of Current Technology Corporation, 800-661-4247, or+1-604-684-2727, or rkramer@current-technology.com; or investors, RichardHannon of Polestar Communications, 866-858-4100
Web site: http://www.current-technology.com//
